Purification process for lipid-membrane-enclosed complex assemblages
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current chromatographic methods fail to effectively separate intact lipid-membrane-enclosed compound assemblages (LMCAs) from chromatin heteroaggregates containing degraded remnants, leading to contamination issues in therapeutic applications, as these methods either capture chromatin heteroaggregates along with LMCAs or struggle to distinguish between LMCAs with varying phosphatidylserine levels on their outer membrane surfaces.
Innovation Solution
A chromatographic method utilizing a chromatographic material with cationic metal affinity ligands, such as ferric iron, manganese, or magnesium ions, and a non-metal-chelating salt gradient to elute intact LMCAs while retaining chromatin heteroaggregates, combined with additional steps like nuclease treatment and anionic chromatography to reduce chromatin content and separate LMCAs based on phosphatidylserine levels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If anion exchange chromatography is used to separate LMCAs from chromatin heteroaggregates, then LMCAs can be eluted with sodium chloride, but chromatin heteroaggregates with lesser amounts of nucleic acids co-elute with intact LMCAs
Solution Approach 1:
The patent changes the chromatographic parameters by using cationic metal affinity chromatography instead of anion exchange chromatography. The stationary phase is charged with ferric iron, manganese, or magnesium ions, and LMCAs are eluted with a non-metal-chelating salt gradient, creating different interaction mechanisms that improve separation between LMCAs and chromatin heteroaggregates
Solution Approach 2:
The patent introduces cationic metal affinity ligands as an intermediary mechanism. These ligands, when charged with metal ions, mediate the interaction between LMCAs and the stationary phase, allowing selective retention and elution that distinguishes LMCAs from chromatin heteroaggregates based on their surface properties
2Manufacturing precision
If size-based purification methods are used, then LMCAs can be separated by size, but chromatin heteroaggregates with similar size ranges cannot be distinguished
Solution Approach 1:
The patent changes from size-based separation parameters to charge-based separation parameters. By using cationic metal affinity chromatography, the separation mechanism shifts from physical size to electrostatic interactions and metal ion affinity, enabling differentiation of particles with overlapping size distributions based on their surface charge and nucleic acid content
3Manufacturing precision
If affinity chromatography methods recognizing LMCAs by membrane proteins are used, then LMCAs can be captured, but chromatin heteroaggregates containing those proteins are also captured
Solution Approach 1:
The patent applies local quality by targeting specific surface properties of LMCAs - particularly phosphatidylserine in the outer membrane leaflets - rather than relying on general protein markers. The cationic metal affinity ligands interact with the charged phospholipid heads and associated proteins, providing localized recognition that distinguishes intact LMCAs from chromatin heteroaggregates
Solution Approach 2:
Instead of using traditional affinity chromatography that captures LMCAs and their contaminants together, the patent inverts the approach by using a method that selectively retains LMCAs while allowing chromatin heteroaggregates to pass through or be separately eluted, reversing the capture-selectivity relationship
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method allows for the efficient separation of intact LMCAs from chromatin heteroaggregates, reducing contamination and enabling the selective fractionation of LMCAs with varying phosphatidylserine levels, meeting regulatory requirements for low DNA levels and enhancing diagnostic test sensitivity.
Implementation Method 1
contacting the sample with a chromatographic material with a surface having cationic metal affinity ligands said chromatographic material being charged with ferric iron, manganese, calcium, or magnesium ions
Implementation Method 2
applying a gradient of a first elution buffer comprising a non-metal-chelating salt, thereby eluting LMCAs
Data Source
AI summary
A chromatographic method for separation of lipid-membrane-enclosed compound assemblages (LMCAs) from chromatin heteroaggregates including degraded remnants from LMCAs in a sample,contacting the sample with a chromatographic material with a surface having cationic metal affinity ligands said chromatographic material being charged with ferric iron, manganese, calcium, or magnesium ions, and being equilibrated with an equilibration buffer,applying a gradient of a first elution buffer comprising a non-metal-chelating salt, therebyeluting LMCAs.